Literature DB >> 5710452

[Are the primary vascular forms of chronic pulmonary heart disease becoming more common?].

H P Gurtner, M Gertsch, C Salzmann, M Scherrer, P Stucki, F Wyss.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5710452

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


× No keyword cloud information.
  21 in total

Review 1.  Appetite suppressants and pulmonary hypertension.

Authors:  N F Voelkel
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

2.  Irreversible pulmonary hypertension after treatment with fenfluramine.

Authors:  J McMurray; P Bloomfield; H C Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

3.  Primary pulmonary hypertension.

Authors:  T Higenbottam
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

4.  [Prevention and therapy of chronic cor pulmonale (author's transl)].

Authors:  H Herzog; C Kopp; A Perruchoud
Journal:  Klin Wochenschr       Date:  1977-08-15

5.  Haemodynamic effects of oral aminorex and amphetamine in unanaesthetized beagle dogs.

Authors:  J A Will; G E Bisgard
Journal:  Thorax       Date:  1972-01       Impact factor: 9.139

6.  Aminorex and the pulmonary circulation.

Authors:  J M Kay; P Smith; D Heath
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

7.  [Functional disorders in primary vasculary diseases of the lung].

Authors:  F Witek
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969-09

8.  [Intrapulmonary right-to-left shunt in lung and heart diseases].

Authors:  R Mürtz
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969-09

9.  [The clinical picture of disturbed pulmonary circulation].

Authors:  N G Orie
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969-09

10.  Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.

Authors:  S Eddahibi; M Humbert; E Fadel; B Raffestin; M Darmon; F Capron; G Simonneau; P Dartevelle; M Hamon; S Adnot
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.